We evaluated platelet accumulation in carotid arteries by means of a dual-radiotracer method, using indium-Ill-labeled platelets and technetium-99m-4abeled human serum albumin, in 123 patients (92 men, 31 women; median age 60 years). Sixty patients had symptoms of transient ischemic carotid artery disease, and 63 patients with peripheral arterial occlusive disease served as controls. Antiplatelet treatment with acetylsalicylic acid was taken by 53 of the 123 patients. In 36 of the 60 symptomatic patients, platelet scintigraphy was repeated 3 -4 days after carotid endarterectomy. Comparison of different scintigraphic parameters (platelet accumulation index and percent of the injected dose of labeled platelets at the carotid bifurcation) showed no significant differences between symptomatic and asymptomatic patients, and the severity of stenosis and the presence of plaque ulceration also had no influence on the parameters. There was no difference between patients with a short (<4 weeks) or long (>4 weeks) interval from the last transient ischemic attack to scintigraphy and no difference between patients with or without antiplatelet treatment. Classifying the patients according to plaque morphology judged by high-resolution real-time ultrasonography also demonstrated no differences. No significant correlation was found between any scintigraphic parameter and other platelet function parameters such as platelet survival time, platelet turnover rate, and concentration of platelet-specific proteins. Quantification of platelet deposition after carotid endarterectomy in 36 patients demonstrated a significant increase of the median platelet accumulation index and the percent injected dose index. There were no significant differences between patients receiving high-dose (1.0 g/day) or low-dose (0.1 g/day) acetylsalicylic acid in scintigraphic results. The presence and amount of scintigraphically detectable platelet deposition after carotid endarterectomy was of no prognostic value concerning the risk of a postoperative neurologic deficit or of developing severe restenosis within the first few months. We conclude that platelet scintigraphy with the dual-radiotracer method has no value in the clinical investigation of carotid artery disease. Intravascular platelet deposition and the in vivo effectiveness of drugs may be monitored scintigraphically by the use of indium-Ill-labeled autologous platelets. However, the results of studies using platelet scintigraphy in carotid atherosclerosis have
been quite variable 3 -9 ; the further application of the dual-radiotracer method 10 also gave divergent results."- 13 Thus, the clinical value of indium-Illlabeled platelet scintigraphy in carotid artery disease still remains to be established. 13 We evaluated platelet accumulation in carotid arteries by means of a dual-radiotracer method, using indium-lll-labeled platelets and technetium99m-labeled human serum albumin (Tc-99m HSA), to answer the following questions: 1) are there differences between symptomatic and asymptomatic patients with carotid lesions and between patients with and without antiplatelet therapy in the amount of platelets accumulated; 2) is the amount of platelets accumulated correlated with the degree of stenosis, plaque morphology (determined by highresolution ultrasound duplex scan), and plaque ulceration (histologic examination after endarterectomy), or with other platelet function parameters (platelet survival time, platelet turnover rate, /3-thromboglobulin concentration, platelet factor 4 concentration); and 3) is the amount of postendarterectomy platelet deposition correlated with restenosis?
Subjects and Methods
We studied 123 patients (92 men, 31 women; median age 64, range 40-83 years). Sixty patients had symptoms of TIA, and 63 patients studied primarily because of peripheral artery occlusive disease served as controls. Antiplatelet treatment with acetylsalicylic acid (ASA) at high (1.0 g/day, rc=32) or low (0.1 g/day, n=2\) doses was being taken by 53 of the 123 patients at the time of scintigraphy. A more detailed characterization of the four groups of patients (symptomatic untreated, symptomatic treated, asymptomatic untreated, asymptomatic treated) is given in Table 1 .
In 36 of the 60 symptomatic patients platelet scintigraphy was repeated 3-4 days after carotid endarterectomy; further follow-up was accomplished by real-time ultrasonography. Due to a prospective, randomized study that is not yet finished, these 36 patients received ASA before and after surgery at high (n=22) or low (n=14) doses. Endarterectomy was performed without intraoperative shunt, with direct arterial suture without patch. None of the 36 patients developed a central neurologic deficit in the immediately postoperative period. The carotid specimens were judged by macroscopic and histologic examination and were categorized as being with or without ulceration (and thrombotic depositions).
Autologous platelets were labeled with ['"In]oxine according to Thakur et al 14 ; median labeling efficiency was 84%. Administered activity ranged between 400 and 700 /iCi (14.8-26 MBq) of indium-111-labeled platelets. Assessment of the labeled platelets revealed no evidence of severe in vitro damage as indicated by normal recovery of the labeled platelets in the circulation (median recovery 2 hours after injection 71%) and by occasional scanning electron microscopy studies demonstrating that most platelets had regained their discoid shape.
Platelet survival time (PST) and platelet turnover rate (PTO) were calculated as described 15 ; /3-thromboglobulin (0-TG) and platelet factor 4 (PF 4) concentrations were determined using commercially available radioimmunoassay kits.
Anterior scintigrams of the head and neck, with inclusion of the upper thorax, were performed 24-30 hours after the injection of labeled platelets. Counts were accumulated for 15 minutes with a large-field-of-view gamma camera (LFOV, Siemens) equipped with a medium-energy, parallelhole collimator. Both gamma photon peaks of indium-111 (172 and 247 KeV) were collected with a 15% energy window and stored in a 128x 128 matrix in a dedicated computer (PDP 11/34, Digital Equipment Corp.).
After the platelet study, 10-15 mCi (370-555 MBq) of Tc-99m HSA was injected intravenously, and a 1-minute blood-pool scintigram of the same region was obtained 10 minutes after the injection. Since the dose of technetium-99m was several times that of indium-111, the fraction of counts due to Compton scatter of indium-111 in the technetium99m energy window was negligible (<3%).
The scintigrams were analyzed four ways: 1. Visual interpretation. Both the indium-111 and the Tc-99m HSA scintigrams were interpreted by one experienced observer (who was unaware of clinical information) regarding focal accumulation of radioactivity at the carotid bifurcation. The scintigrams were graded as positive (a region of markedly increased activity only on the indium-111 scintigram, Figure 1 ), equivocal (area of slight increase only on the indium-111 scintigram or apparently unequal increases of activity at corresponding sites of both scintigrams, Figure 2 ), or negative (no apparent areas of increased activity or equally increased activities at corresponding sites of both scintigrams).
2. Corrected ratio. An observer-independent evaluation was done by accumulating counts from a region of interest encompassing both carotid bifurcations on the indium-111 scintigram and calculating symptomatic: contralateral side ratios in symptomatic patients and right: left ratios in asymptomatic patients. The same was done for the Tc-99m HSA scintigram to allow correction for the blood-pool radioactivity and to determine a corrected ratio as Ins/In^Tcs/Tcc, where In s and Inc are the total activities of indium-111 in the region of interest at the symptomatic (or right) and contralateral (or left) carotid arteries, respectively, and Tc s and Tc c are the activities of Tc-99m HSA in the symptomatic (or right) and contralateral (or left) carotid arteries, respectively.
3. Platelet accumulation index (PAI). Regions of interest were drawn over the carotid bifurcation (see above) and the pulmonary artery, which was chosen as a reference region since the pulmonary artery represents an area with absent or minimal platelet deposition. The ratio of the activity of indium-111-labeled platelets deposited on the vascular wall to the activity of those circulating in the blood pool at the carotid bifurcation was determined as PAI, which was calculated according to Isaka et al" as Ins/ln R :TcsA"c R -1, where In s and Tc s are defined as above, In R is the indium-111 activity in the reference region, and Tc R is the activity of Tc-99m HSA in the reference region.
4. Percent injected dose (%ID) index. The percent of the injected dose of indium-111-labeled platelets that accumulated at the carotid bifurcation was calculated according to Powers et proposed a measurement of platelet deposition that is independent of the circulating concentration of labeled platelets, which may vary depending on the administered dose, the initial amount of splenic sequestration, and the subsequent rate of platelet destruction. %ID index can be derived by multiplying PA1 by the percent injected dose of indium-111-labeled platelets in 1 ml of blood drawn concurrently.
The ultrasound investigations of the carotid bifurcation were done using a "Face one Biosound" (Biosound, Inc., Indianapolis, Indiana) highresolution ultrasound real-time duplex system (with a 8-MHz probe with a built-in pulsed Doppler). According to their surface judged by ultrasonography, plaques were classified as smooth, rough, or ulcerated. Thickness of the thrombotic deposits on the new inner surface of the operated artery was examined 3-4 days after carotid endarterectomy.
We compared the symptomatic (or right) and contralateral (or left) carotid arteries and the preoperative and postoperative parameters using Wilcoxon's signed rank test for paired data and compared the various groups of patients using Wilcoxon's rank sum test for unpaired data and analysis of variance (Kruskal-Wallis test).
Results
The results of the scintigraphic studies are listed in Table 2 . By visual interpretation, only three of 60 symptomatic patients (5%) had a positive result, and one of these three was positive in the region of the contralateral carotid artery; 10 scintigrams were classified as equivocal. The 10 equivocal scintigrams appeared abnormal by visual interpretation of the indium-Ill scintigram and had concurrent but lesser findings on the Tc-99m HSA blood-pool scintigram (see Figure 2) . PAI and %ID index did not differ between groups or between patients with >50% or <50% stenosis of the internal carotid artery; there were no differences between patients with a short (<4 weeks) or long (>4 weeks) interval from the last TIA to scintigraphy. There were also no differences between patients with and without ulceration of the endarterectomy specimen; median PAI in the nine patients with ulceration was 5.33 and in the 27 patients without ulceration -4.9, but the difference was not significant (p=0.07). Classifying the patients according to plaque morphology also revealed no differences in any parameter.
PST, PTO, /3-TG, and PF 4 are listed in Table 3 . There were no significant differences between groups for any platelet function parameter. No significant correlation was found between these parameters and any scintigraphic parameter. There were also no differences between patients treated with highor low-dose ASA with respect to any scintigraphic parameter; PST, PTO, /3-TG, and PF 4 also did not differ.
Scintigraphic and platelet function parameters of the 36 patients studied before and after carotid endarterectomy are given in Table 4 . The postoperative corrected ratio, PAI, %ID index, and PTO were significantly greater than preoperative values. There were no significant differences between patients receiving high-or low-dose ASA in scintigraphic parameters. There was no correlation between the thickness of the thrombotic layer and PAI or %LD index.
Twenty-seven of the 36 patients have been observed for at least 3 months after endarterectomy. Sonography demonstrated a restenosis of >50% in eight; 19 had no (n=13) or only moderate (n=6) restenosis. There were no significant differences between patients with and without severe restenosis in immediately postoperative scintigraphic or platelet function parameters.
Discussion
Pathologic and clinical studies indicate that platelets play an important role in the pathogenesis of cerebral ischemic syndromes since a substantial number of attacks may arise from platelet-fibrin emboli that originate from lesions in the carotid arteries. 1617 In recent years, indium-Ill-labeled platelet scintigraphy has been used with high expectations to identify such carotid lesions, but the results of these studies have been quite variable. Scintigraphic evidence of platelet deposition on arteriographically confirmed plaques has ranged from 0% to 78%. 18 Powers et al 6 reported that scintigrams of symptomatic and asymptomatic carotid arteries were equally likely to be abnormal.
There was also no correlation between the scintigraphic results and the time elapsed since the most recent event, the arteriographic presence of plaque ulceration, the degree of stenosis, and the clinical follow-up. These negative results were believed to be due to methodologic problems since qualitative scintigraphy may be insufficiently sensitive to detect small foci of platelet deposition. Thus, a semiquantitative approach was introduced with a dualradiotracer method. 10 Using this method in 25 patients with carotid atherosclerosis, Isaka et al 
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Platelet factor 4 concentration (ng/ml) Median Qr-Q 3 34 arteriographically abnormal and in one of 16 arteriographically normal sites. Mean PAI was significantly higher when ulceration was present and when the stenosis was >50%. Kessler et al 12 also reported an improvement of the results by use of the dual-radiotracer method, whereas Powers 13 found no improvement in the sensitivity of detecting carotid atherosclerosis.
Our results are in accordance with the findings of Powers. 13 The PAI values were not different between symptomatic and asymptomatic patients, and the severity of stenosis and the presence of plaque ulceration had no influence on the scintigraphic parameters. This is in contrast to the results of Isaka et al," who performed scintigraphy 48 hours after the injection of labeled platelets; in our study the scintigrams were obtained after 24- and Isaka et al, 11 we could not demonstrate any difference between patients with short and long intervals from the last TIA to the scintigraphic study or between patients with and without antiplatelet treatment, whereas Kessler et al 19 reported an increased frequency of positive results in untreated compared with treated patients.
From our results it appears that platelet scintigraphy with the dual-radiotracer method has no value in the clinical investigation of carotid artery disease. The only advantage of the dual-radiotracer method seems to be the possibility of verifying many of the formerly judged positive scintigraphic results as falsely positive since the apparently increased activity is often caused by increased blood-pool activity and not by increased platelet deposition.
Because of our nonsignificant results, however, one must consider that the statistical tests we applied are not designed to prove equality of the measured parameters in different groups.
It is clear that for a positive scintigram a certain amount of labeled platelets is necessary, and scintigraphy may not be sensitive enough to detect small platelet thrombi that are nevertheless of a size sufficient to cause clinical symptoms. Goldman et al 20 concluded from a theoretical study with neck phantom images that a platelet thrombus must contain a minimal activity 4-8 times that in 1 ml of blood to be detectable scintigraphically. In accordance with these findings, Ezekowitz et al 8 reported negative scintigraphic results in patients whose carotid plaques had less activity than 1 ml of blood. The lack of correlation between scintigraphy and clinical parameters could also be explained by the suggestion that platelet thrombi are present only transiently and are no longer present when scintigraphy is performed.
Lusby et al 21 have used a canine model to investigate healing after carotid endarterectomy and the validity of indium-lll-labeled platelet scintigraphy to assess postendarterectomy platelet deposition. Endarterectomized arteries showed uptake of platelets immediately after infusion, reaching a maximum by 1 hour, with little increase at 24 or 48 hours. When labeled platelets were infused 7-9 days after endarterectomy, only eight of 14 arteries showed uptake. A similar study was carried out in 17 patients after carotid endarterectomy for symptoms of TIA. Labeled platelets were infused within 1 hour of closure of the endarterectomy; scintigraphy was performed 3-6 hours later, and subsequent images were obtained 24-48 hours after surgery. Platelet uptake was present in 16 patients, but no further quantification was done. Recently, Stratton et al 22 reported a study with assessment of platelet deposition at endarterectomy sites. Labeled platelets were injected within 30 minutes after carotid endarterectomy, with imaging 24-% hours later. They observed a mean deposition index (ratio of activity in the operated carotid artery and that of the contralateral side) of 1.7±0.5. However, they did not use a dual-radiotracer method, and they could not exclude the possibility of platelet accumulation outside the vessel; furthermore, the use of antithrombotic drugs was not controlled.
To avoid any misinterpretation of our results caused by platelet accumulation in a hematoma, we labeled platelets 3-4 days after endarterectomy. The quantification of platelet deposition demonstrated a significant increase of median PAI and %ID index compared with preoperative studies. Most important seems the lack of correlation between the amount of postoperative platelet deposition and the development of severe restenosis within 3 months postoperatively. Theoretically, one would expect such a correlation because it has been described that platelet deposition leads to release of platelet-derived smooth muscle mitogens that stimulate smooth muscle cell proliferation and thus contribute to vessel wall narrowing. 2324 Our postendarterectomy study has shown that scintigraphically detectable, and therefore massive, platelet deposition is still present 4-5 days after carotid endarterectomy in approximately half of the patients despite antiplatelet therapy. However, this observation seems to be of no clinical importance since the presence and amount of platelet deposition has no prognostic value concerning the risk of postoperative neurologic deficit or severe restenosis within the first few months.
